+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Multiple Osteochondromas (MO) - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple Osteochondromas (MO) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Astrocytoma - Pipeline Insight, 2024 - Product Thumbnail Image

Astrocytoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Nonmelanoma Skin Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Nonmelanoma Skin Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
CNS Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

CNS Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Bone Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Bone Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Myeloproliferative Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Myeloproliferative Neoplasms - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Plasmacytoma - Pipeline Insight, 2024 - Product Thumbnail Image

Plasmacytoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Radiologic Cancer Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Radiologic Cancer Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Relapsed B-Cell Small Lymphocytic Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed B-Cell Small Lymphocytic Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Squamous Cell Carcinoma of the Lung - Pipeline Insight, 2024 - Product Thumbnail Image

Squamous Cell Carcinoma of the Lung - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Zollinger Ellison Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Ependymoma - Pipeline Insight, 2024 - Product Thumbnail Image

Ependymoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Renal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
CAR-T Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 550 Pages
  • Global
From
Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Chemotherapy Induced Neutropenia - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Neutropenia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more